Bi(o)communications among peripheral blood fractions: A focus on NK and NKT cell biology in rheumatoid arthritis

Autoimmunity

Volumn 46, Issue 4, 2013, Pages 238-250

  Aggarwal, Ashish ^a   Sharma, Aman ^b   Bhatnagar, Archana ^a  

^a PANJAB UNIVERSITY   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Apoptosis; DAS28; DNA fragmentation; Mitochondrial membrane potential; Oxidative stress

Indexed keywords

CASPASE 3; CATALASE; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLOGY; DAS28; DISEASE ACTIVITY SCORE; DISEASE SEVERITY; DNA DAMAGE; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; HUMAN; IMMUNOBIOLOGY; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE POTENTIAL; NATURAL KILLER CELL; NATURAL KILLER T CELL; OXIDATIVE STRESS; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PERIPHERAL LYMPHOCYTE; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION;

ADULT; ANTIGENS, CD95; ARTHRITIS, RHEUMATOID; CASE-CONTROL STUDIES; CATALASE; DNA DAMAGE; ERYTHROCYTES; FAS LIGAND PROTEIN; FEMALE; GLUTATHIONE; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MIDDLE AGED; NATURAL KILLER T-CELLS; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SUPEROXIDE DISMUTASE;

EID: 84877754164     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2012.755959     Document Type: Article

References (69)

1. Seven, A., S. Guzel, M. Aslan, and V. Hamuryudan. 2008. Lipid, protein, DNA oxidation and antioxidant status in rheumatoid arthritis. Clin. Biochem. 41: 538-543
2. Darlington, L. G., and T. W. Stone. 2001. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 85: 251-269
3. Vinay, D. S., and B. S. Kwon. 2012. Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. Cytokine 57: 305-312
4. Szabo-Taylor, K. E., P. Eggleton, C. A. Turner, et al. 2012. Lymphocytes from rheumatoid arthritis patients have elevated levels of intracellular peroxiredoxin 2, and a greater frequency of cells with exofacial peroxiredoxin 2, compared with healthy human lymphocytes. Int J Biochem Cell Biol 44: 1223-1231
5. Passos, J. F., G. Saretzki, and T. von Zglinicki. 2007. DNA damage in telomeres and mitochondria during cellular senescence: Is there a connection? Nucl. Acids Res. 35: 7505-7513
6. Rasheed, Z., M. W. Khan, and R. Ali. 2006. Hydroxyl radical modification of human serum albumin generated cross reactive antibodies. Autoimmunity 39: 479-488
7. Kennedy, A., C. T. Ng,M. Biniecka, et al. 2010. Angiogenesis and blood vessel stability in inflammatory arthritis. Arthritis Rheum. 62: 711-721
8. Biniecka, M., A. Kennedy, U. Fearon, et al. 2010. Oxidative damage in synovial tissue is associated with in vivo hypoxic status in the arthritic joint. Ann. Rheum. 69: 1172-1178
9. Kaszubowska, L., J. J. Kaczor, L. Hak, et al. 2011. Sensitivity of natural killer cells to activation in the process of ageing is related to the oxidative and inflammatory status of the elderly. Physiol. Pharmacol. 62: 101-109
10. Prasad, K. V., and B. S. Prabhakar. 2003. Apoptosis and autoimmune disorders. Autoimmunity 36: 323-330
11. Radisky,D. C.,D. D. Levy, L. E. Littlepage, et al. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127
12. Hirao, M., N. Yamasaki, H. Oze, et al. 2011. Serum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab. Rheumatol. Int. doi:10.1007/s00296-00011-02135-00290
13. Ahern, D. J., and F. M. Brennan. 2011. The role of Natural Killer cells in the pathogenesis of rheumatoid arthritis: Major contributors or essential homeostatic modulators? Immunol. Lett. 136: 115-121
14. Shegarfi, H., F. Naddafi, and A. Mirshafiey. 1974. Natural killer cells and their role in rheumatoid arthritis: Friend or foe? World J. 2012: 491-974
15. Gao,N., T. Dang, andD. Yuan. 2011. IFN-gamma-dependent and -independent initiation of switch recombination by NK cells. J. Immunol. 167-2018
16. Tarazona, R., O. DelaRosa, E. Peralbo, et al. 2003. Human NKT cells in health and disease. Inmunologia 22: 359-370
17. Caligiuri, M. A. 2008. Human natural killer cells. Blood 112: 461-469
18. Andoniou, C. E., J. D. Coudert, and M. A. Degli-Esposti. 2008. Killers and beyond: NK-cell-mediated control of immune responses. Eur. J. Immunol. 38: 2938-2942
19. Cerboni, C., A. Zingoni, M. Cippitelli, et al. 2007. Antigenactivated human T lymphocytes express cell-surface NKG2D ligands via an ATM/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis. Blood 110: 606-615
20. Zingoni, A., T. Sornasse, B. G. Cocks, et al. 2004. Cross-talk between activated human NK cells and CD4 + T cells via OX40-OX40 ligand interactions. J. Immunol. 173: 3716-3724
21. Gerosa, F., B. Baldani-Guerra, C. Nisii, et al. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195: 327-333
22. Soderstrom, K., E. Stein, P. Colmenero, et al. 2010. Natural killer cells trigger osteoclastogenesis and bone destruction in arthritis. Proc. Natl. Acad. Sci. USA 107: 13028-13033
23. Rabinovich, B. A., J. Li, J. Shannon, et al. 2003. Activated, but not resting, T cells can be recognized and killed by syngeneic NK cells. J. Immunol. 170: 3572-3576
24. Wen, T., Y. Li, M. Wu, et al. 2012. Therapeutic effects of a novel Tylophorine analog NK-007 on collagen-induced arthritis through suppressing TNF-alpha production and Th17 differentiation. Arthritis Rheum 64: 2896-2906
25. Kohara, H., H. Kitaura, Y. Fujimura, et al. 2011. IFN-gamma directly inhibits TNF-alpha-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions. Immunol. Lett. 137: 53-61
26. Ardolino, M., A. Zingoni, C. Cerboni, et al. 2011. DNAM-1 ligand expression on Ag-stimulated T lymphocytes is mediated by ROS-dependent activation of DNA-damage response: Relevance for NK-T cell interaction. Blood 117: 4778-4786
27. Hansson, M., A. Asea, U. Ersson, S. Hermodsson, and K. Hellstrand. 1996. Induction of apoptosis in NK cells by monocyte-derived reactive oxygen metabolites. J. Immunol. 156: 42-47
28. Aletaha, D., T. Neogi, A. J. Silman, et al. 2010. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum Dis. 69: 1580-1588
29. Prevoo, M. L., M. A. van 't Hof, H. H. Kuper, et al. 1995. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38: 44-48
30. Kay, H. D. 1980. A new procedure to overlay diluted blood on Ficoll-hypaque gradients. J. Immunol. Meth. 39: 81-83
31. Buege, J. A., and S. D. Aust. 1978. Microsomal lipid peroxidation. Meth. Enzymol. 52: 302-310
32. Beutler, E., O. Duron, and B. M. Kelly. 1963. Improved method for the determination of blood glutathione. J. Lab. Clin. Med. 61: 882-888
33. Kono, Y. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186: 189-195
34. Luck, H. 1971. Catalase, methods of enzymatic analysis. In Methods of Enzymatic Analysis. H. U. Bergmeyer, ed. Academic Press, New York. p. 885-893
35. Paglia, D. E., and W. N. Valentine. 1967. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70: 158-169
36. Lowry, O. H., N. J. Rosebrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
37. Singh, N. P., M. T. McCoy, R. R. Tice, and E. L. Schneider. 1988. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell. Res. 175: 184-191
38. Lanier, L. L., R. Testi, J. Bindl, and J. H. Phillips. 1989. Identity of Leu-19 (CD56) leukocyte differentiation antigen and neural cell adhesion molecule. J. Exp. Med. 169: 2233-2238
39. Sarkar, M., R. Varshney, M. Chopra, et al. 2006. Flowcytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patients with thyroid dysfunction. Cytometry B Clin. Cytom. 70: 20-23
40. Oates, J. C. 2010. The biology of reactive intermediates in systemic lupus erythematosus. Autoimmunity 43: 56-63
41. Ivashchenko, O., P. P. Van Veldhoven, C. Brees, et al. 2011. Intraperoxisomal redox balance in mammalian cells: Oxidative stress and interorganellar cross-talk. Mol. Biol. Cell 22: 1440-1451
42. Kregel, K. C., and H. J. Zhang. 2007. An integrated view of oxidative stress in aging: Basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292: R18-R36
43. Shah, D., R. Kiran, A. Wanchu, and A. Bhatnagar. 2010. Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity. Immunol. Lett. 129: 7-12
44. Mellqvist, U. H., M. Hansson, M. Brune, et al. 2000. Natural killer cell dysfunction and apoptosis induced by chronic myelogenous leukemia cells: Role of reactive oxygen species and regulation by histamine. Blood 96: 1961-1968
45. Kurien, B. T., and R. H. Scofield. 2008. Autoimmunity and oxidatively modified autoantigens. Autoimmun. Rev. 7: 567-573
46. Winyard, P. G., B. Ryan, P. Eggleton, et al. 2011. Measurement and meaning of markers of reactive species of oxygen, nitrogen and sulfur in healthy human subjects and patients with inflammatory joint disease. Biochem. Soc. Trans. 39: 1226-1232
47. Lopez, L. R., D. F. Simpson, B. L. Hurley, and E. Matsuura. 2005. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: Pathogenic implications for vascular involvement. Ann. NY Acad. Sci. 1051: 313-322
48. Ahmad, R., Z. Rasheed, and H. Ahsan. 2009. Biochemical and cellular toxicology of peroxynitrite: Implications in cell death and autoimmune phenomenon. Immunopharmacol. Immunotoxicol. 31: 388-396
49. Wu, Z., I. A. MacPhee, and D. B. Oliveira. 2004. Reactive oxygen species in the initiation of IL-4 driven autoimmunity as a potential therapeutic target. Curr. Pharm. Des. 10: 899-913
50. Flodstrom-Tullberg, M., Y. T. Bryceson, F. D. Shi, P. Hoglund, and H. G. Ljunggren. 2009. Natural killer cells in human autoimmunity. Curr. Opin. Immunol. 21: 634-640
51. Zakka, L. R., E. Fradkov, D. B. Keskin, et al. 2012. The role of natural killer cells in autoimmune blistering diseases. Autoimmunity 45: 44-54
52. Lo, C. K., Q. L. Lam, L. Sun, et al. 2008. Natural killer cell degeneration exacerbates experimental arthritis in mice via enhanced interleukin-17 production. Arthritis Rheum. 58: 2700-2711
53. Walzer, T., M. Blery, J. Chaix, et al. 2007. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc. Natl. Acad. Sci. USA 104: 3384-3389
54. Erkeller-Yusel, F., F. Hulstaart, I. Hannet, D. Isenberg, and P. Lydyard. 1993. Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus. Lupus 2: 227-231
55. Munschauer, F. E., L. A. Hartrich, C. C. Stewart, and L. Jacobs. 1995. Circulating natural killer cells but not cytotoxic T lymphocytes are reduced in patients with active relapsing multiple sclerosis and little clinical disability as compared to controls. J. Neuroimmunol. 62: 177-181
56. Mieza, M. A., T. Itoh, J. Q. Cui, et al. 1996. Selective reduction of V alpha 14 + NK T cells associated with disease development in autoimmune-prone mice. J. Immunol. 156: 4035-4040
57. Godfrey, D. I., S. J. Kinder, P. Silvera, and A. G. Baxter. 1997. Flow cytometric study of T cell development in NOD mice reveals a deficiency in alphabetaTCR + CDR-CD8- thymocytes. J. Autoimmun. 10: 279-285
58. Sumida, T., A. Sakamoto, H. Murata, et al. 1995. Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J. Exp. Med. 182: 1163-1168
59. Wilson, S. B., S. C. Kent, K. T. Patton, et al. 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature 391: 177-181
60. Cho, Y. N., S. J. Kee, S. J. Lee, et al. 2011. Numerical and functional deficiencies of natural killer T cells in systemic lupus erythematosus: Their deficiency related to disease activity. Rheumatology (Oxford) 50: 1054-1063
61. Zhang, H. L., S. Azimullah, X. Y. Zheng, et al. 2012. IFN-gamma deficiency exacerbates experimental autoimmune neuritis in mice despite a mitigated systemic Th1 immune response. J. Neuroimmunol. 246: 18-26
62. Cooper, M. A., T. A. Fehniger, A. Fuchs, M. Colonna, and M. A. Caligiuri. 2004. NK cell and DC interactions. Trends Immunol. 25: 47-52
63. Ferrer, P. E., P. Frederick, J. M. Gulbis, G. Dewson, and R. M. Kluck. 2012. Translocation of a bak C-terminus mutant from cytosol to mitochondria to mediate cytochrome c release: Implications for bak and bax apoptotic function. PLoS One 7: e31510
64. Cooke, M. S., M. D. Evans, M. Dizdaroglu, and J. Lunec. 2003. Oxidative DNA damage: Mechanisms, mutation, and disease. FASEB J. 17: 1195-1214
65. Staron, A., G. Makosa, and M. Koter-Michalak. 2012. Oxidative stress in erythrocytes from patients with rheumatoid arthritis. Rheumatol. Int. 32: 331-334
66. Peng, S. L. 2006. Fas (CD95)-related apoptosis and rheumatoid arthritis. Rheumatology (Oxford) 45: 26-30
67. Shah, D., A. Aggarwal, A. Bhatnagar, R. Kiran, and A. Wanchu. 2011. Association between T lymphocyte subsets apoptosis and peripheral blood mononuclear cells oxidative stress in systemic lupus erythematosus. Free Radic Res 45: 559-567
68. Haupt, S., M. Berger, Z. Goldberg, and Y. Haupt. 2003. Apoptosis-The p53 network. J Cell Sci 116: 4077-4085
69. Wang, X., A. Ottosson, C. Ji, et al. 2009. Proteasome inhibition induces apoptosis in primary human natural killer cells and suppresses NKp46-mediated cytotoxicity. Haematologica 94: 470-478